BRT offers in vitro approaches to evaluate respiratory sensitization, hypersensitivity, and associated immune responses using human cell-based and complementary assays.
BRT offers an in vitro approach for evaluating respiratory sensitization responses.
BRT offers complementary in vitro assessments to further characterize immune responses associated with hypersensitivity.
In vitro respiratory sensitization and hypersensitivity assessments can be integrated with BRT’s in vivo models to support customized evaluation of immune responses.
BRT works with clients to develop customized respiratory sensitization and hypersensitivity studies based on specific research objectives, test articles, assays, and immune response endpoints.